Track topics on Twitter Track topics that are important to you
SOURCE: Johnson & Johnson
No question about it, the lung cancer field is hot—and chock-full of new drugs and combos. But there's a dearth of treatments specifically for early-stage disease, and Johnson & Johnson is looking to crowdsourcing to bring in new ideas.
It's doing that through its latest QuickFire contest at JLABS, the company's internal life sciences incubator. The winner of the Lung Cancer Innovation QuickFire Challenge will earn a yearlong residency at JLABS @ Shanghai, the newest of its 11 labs around the world.
KEYWORDS: johnson & johnson, lung cancer, Lung Cancer Innovation QuickFire Challenge, preventing disease
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...